Neogen Chemicals Limited announced the successful conclusion of its 37th Annual General Meeting (AGM) held on August 21, 2026. All resolutions presented to the shareholders were duly approved with the requisite majority. These included the adoption of the Audited Standalone and Consolidated Financial Statements for the fiscal year ended March 31, 2026, declaration of a final dividend, the re-appointment of a director, authorization for securities issuance, and ratification of cost auditor remuneration.
Neogen Chemicals Concludes 37th Annual General Meeting
Neogen Chemicals Limited successfully convened its 37th Annual General Meeting (AGM) on Friday, August 21, 2026. The meeting, which commenced at 5:00 p.m. IST and concluded at 6:31 p.m. IST, was conducted via Video Conferencing / Other Audio Video Means (VC/OAVM). All businesses as stated in the Notice of the 37th AGM were transacted.
Key Resolutions Approved by Shareholders
The company reported that all resolutions put forth during the AGM were approved by the shareholders with the necessary majority. The Scrutinizers’ Report, prepared by CS Devendra Deshpande from DVD & Associates, confirms the consolidated voting results on both remote e-voting and e-voting conducted during the AGM. The resolutions passed included:
- Ordinary Business:
- To receive, consider, and adopt the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, along with the Reports of the Board of Directors and Auditors.
- To declare a final dividend of Re. 1/- per equity share on fully paid-up equity shares of face value Rs. 10/- each for the financial year ended March 31, 2026.
- To appoint a director in place of Dr. Harin Kanani, who retires by rotation and offers himself for re-appointment.
- Special Business:
- To authorize the issuance of securities through permissible modes of fund-raising.
- Ratification of remuneration payable to the cost auditor.
Voting Results Overview
The voting results indicate strong shareholder support across all resolutions. For ordinary business items (Resolutions 1, 2, 3, and 5), all were passed with the requisite majority. Resolution 4, pertaining to the authorization of securities issuance, was also passed as a Special Resolution, signifying overwhelming approval for future fundraising activities.
The detailed Scrutinizers’ Report and the consolidated voting results are available on the Company’s website at https://neogenchem.com/financial-performance/#all tab|1 under the FY 2025-26 section.
Source: BSE
